EUCTR2013-005629-21-HU进行中（未招募）不适用
Diagnostic use of 99mTecnetium labeled infliximab in Crohn’s disease
First Department of Medicine, University of Szeged0 个研究点开始时间: 2014年6月11日最近更新:
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •18-75 years of age. Ileal, colonic or ileocolonic Crohn's disease. Infliximab therapy due to active, refractory Crohn’s disease. Excluded pregnancy.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Known allergy or intolerance to one of the medicaments or their ingredients utilized in the study .
- •Pregnancy and breast feeding. Concomitant severe infections. TB.
- •Sepsis. Abscess. Opportunistic infections. Moderate or severe heart failure (NYHA III/IV). Malignant diseases. Mental impairment, addicitve or other disorders leading to the patients inability to understand the scope and possible consequences of a participation in the clinical trial.
研究者
相似试验
进行中（未招募）
1 期
99Tc labled Inliximab for evaluation of inflammatory activity in patients with inflammtory bowel disease (IBD)EUCTR2007-000842-11-ATMedical University of Graz
进行中（未招募）
不适用
Tracer for the imaging of disease activity in sarcoidosis in the lungPulmonary sarcoidosisMedDRA version: 17.0Level: PTClassification code 10037430Term: Pulmonary sarcoidosisSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersEUCTR2011-003630-13-NLSint Antonius Hospital
已完成
不适用
Possibilities of measuring Infliximab in patients with Ulcerative Colitis or Crohn's ColitisInflammatory Bowel Diseases10017969NL-OMON37225Academisch Medisch Centrum12
已完成
2 期
Infliximab effectiveness in COVID-19 patientsIRCT20201229049873N1Shahre-kord University of Medical Sciences40
进行中（未招募）
1 期
A comparison of a radioactive imaging method with an existing immunological (involving cells from the Immune System) based method that involves staining of tissues from a patient with a known rheumatoid arthritic joint.MedDRA version: 23.1Level: PTClassification code 10039073Term: Rheumatoid arthritisSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersRheumatoid arthritisEUCTR2018-003418-41-GBavidea Biopharmaceuticals Ltd24